ClinicalTrials.govpublic full text
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older
covid-19 immunization, influenza immunization, covid-19 vaccine, influenza vaccine, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 801590
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.